A functional assay-based procedure to classify mismatch repair gene variants in Lynch syndrome.

Genet Med 2019 07 3;21(7):1486-1496. Epub 2018 Dec 3.

Department of Oncological Sciences, Huntsman Cancer Institute, University of Utah School of Medicine, Salt Lake City, UT, USA.

Purpose: To enhance classification of variants of uncertain significance (VUS) in the DNA mismatch repair (MMR) genes in the cancer predisposition Lynch syndrome, we developed the cell-free in vitro MMR activity (CIMRA) assay. Here, we calibrate and validate the assay, enabling its integration with in silico and clinical data.

Methods: Two sets of previously classified MLH1 and MSH2 variants were selected from a curated MMR gene database, and their biochemical activity determined by the CIMRA assay. The assay was calibrated by regression analysis followed by symmetric cross-validation and Bayesian integration with in silico predictions of pathogenicity. CIMRA assay reproducibility was assessed in four laboratories.

Results: Concordance between the training runs met our prespecified validation criterion. The CIMRA assay alone correctly classified 65% of variants, with only 3% discordant classification. Bayesian integration with in silico predictions of pathogenicity increased the proportion of correctly classified variants to 87%, without changing the discordance rate. Interlaboratory results were highly reproducible.

Conclusion: The CIMRA assay accurately predicts pathogenic and benign MMR gene variants. Quantitative combination of assay results with in silico analysis correctly classified the majority of variants. Using this calibration, CIMRA assay results can be integrated into the diagnostic algorithm for MMR gene variants.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41436-018-0372-2DOI Listing
July 2019
27 Reads
7.329 Impact Factor

Publication Analysis

Top Keywords

cimra assay
24
correctly classified
12
mmr gene
12
integration silico
12
gene variants
12
assay
9
lynch syndrome
8
mismatch repair
8
variants
8
bayesian integration
8
predictions pathogenicity
8
silico predictions
8
cimra
6
mmr
5
database biochemical
4
biochemical activity
4
classification bayesian
4
gene database
4
pathogenicity increased
4
variants 87%
4

References

(Supplied by CrossRef)
Article in Nat Rev Cancer
HT Lynch et al.
Nat Rev Cancer 2015
Article in Biomark Med
SV Tavtigian et al.
Biomark Med 2014
Article in Genet Med
H LaDuca et al.
Genet Med 2014
Article in Front Oncol
TP Slavin et al.
Front Oncol 2015
Article in Genet Med
LR Susswein et al.
Genet Med 2016
Article in Hum Mutat
DE Goldgar et al.
Hum Mutat 2008
Article in Hum Mutat
SE Plon et al.
Hum Mutat 2008
Article in Fam Cancer
RH Sijmons et al.
Fam Cancer 2013
Article in Hum Mutat
BA Thompson et al.
Hum Mutat 2013
Article in Hum Mutat
BA Thompson et al.
Hum Mutat 2013
Article in Nat Genet
BA Thompson et al.
Nat Genet 2014

Similar Publications